Drug Manufacturers Watch List: Johnson & Johnson (NYSE:JNJ), Bristol-Myers Squibb (NYSE:BMY), Eli Lilly (NYSE:LLY), AstraZeneca (ADR) (NYSE:AZN)

Lawyers for Johnson & Johnson (NYSE:JNJ) are to argue before the Arkansas Supreme Court that a $1.2 billion judgment over its marketing of the antipsychotics drug Risperdal should be overturned. Johnson & Johnson (NYSE:JNJ) stock opened at $91.11 in last session, and closed at $91.11, while the day range of JNJ stock is $90.77 – $91.54. The stock showed a positive weekly performance of 0.13%.

Bristol-Myers Squibb Co (NYSE:BMY) announced Tuesday that the U.S. Food and Drug Administration has approved its drug to treat rare and potentially fatal body fat disorder, Reuters reported. Bristol-Myers Squibb Co (NYSE:BMY) stock opened at $53.64, in last session and closed at $53.57, by losing -0.20%. The 52 week range of BMY is $36.31 – $56.83. Company’s market capitalization is $88.40billion.

A $5 million gift from the Eli Lilly and Co (NYSE:LLY) Foundation to the YMCA’s Strengthening the Heart of the City Campaign specifically targets the second of the three facilities, the YMCA at CityWay, which would serve downtown and nearby underserved neighborhoods. Eli Lilly and Co (NYSE:LLY) stock advanced 0.31% and finished the last session at $58.66. The EPS of the stock remained 4.31. Company’s market capitalization is $66.81billion.

AstraZeneca plc (ADR) (NYSE:AZN) has received the US Food and Drug Administration (FDA) approval for orphan drug Myalept (metreleptin for injection), which is indicated as an adjunct to diet as replacement therapy for the treatment of complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy. AstraZeneca plc (ADR) (NYSE:AZN) stock opened the session at $67.89, and closed the session at $67.80. The 52 week range of the AZN stock remained $44.62 – $68.53 and the day range was $67.60 – $67.97.